Prenatal Genetic Testing Market size was valued at US$ 12.13 Bn in 2023 and is expected to reach US$ 17.76 Bn in 2030. The Global Prenatal Genetic Testing Market is expected to grow at a CAGR of 5.6% through the forecast period.Prenatal Genetic Testing Market Overview
Prenatal testing includes prenatal screening and diagnosis, which are parts of prenatal treatment that aim to discover pregnancy abnormalities as early as possible. These are anatomic and physiologic issues with the health of the zygote, embryo, or fetus, either before or as early in gestation as possible. Prenatal genetic testing has emerged as a crucial component of modern obstetric care, which has revolutionized the landscape of fetal health assessment. The global prenatal genetic testing market is majorly driven by advancements in genetic technologies and growing awareness among expecting parents, plays an important role in identifying potential genetic abnormalities, chromosomal disorders, and hereditary conditions during pregnancy.To know about the Research Methodology :- Request Free Sample Report
Prenatal Genetic Testing Market Dynamics
Prenatal Genetic Testing Market Driver: Rising Maternal Age Advanced maternal age refers to a pregnancy in which the individual giving birth is older than 35 years. Pregnant individuals in this age group face a higher risk of complications such as miscarriage, congenital disorders, and high blood pressure. Screening tests play a crucial role in detecting specific congenital disorders. This increasing the demand for tests, whch is contributing to the Prenatal Genetic Testing Market growth. While genetic screening tests are recommended for all pregnancies, they become particularly significant for individuals of advanced maternal age. These noninvasive screenings, conducted through blood tests or ultrasound, are optional and can identify if the baby is at a heightened risk for certain congenital conditions. It's important to note that these tests are screenings, indicating they detect the possibility of a genetic condition. In cases where a screening test indicates a potential issue, invasive genetic testing methods may be employed. Chronic villus sampling (CVS) is one such method, using cells from the placenta to diagnose genetic conditions. Amniocentesis is another invasive testing procedure, involving the insertion of a needle through the abdomen to extract amniotic fluid from the uterus. This fluid analysis aids in diagnosing certain genetic conditions. Prenatal Genetic Testing Market Opportunity: Technological Advancement The utilization of Next Generation Sequencing (NGS)-based methods has been predominant, but ongoing technological advancements, including qPCR, dPCR, and amplification technologies, aim to improve test quality and reduce costs. The commercial sector is expanding its focus to encompass sex chromosome aneuploidies, rare autosomal trisomies, and sub-microscopic copy-number variants. Automated in-lab workflows and remote patient monitoring during pregnancy are empowering providers to effectively manage pregnancies and associated risks. A new generation of screening tests is emerging, promising to enhance pregnancy management by offering real-time information about placental development through trophoblast cells. This indicates a shift towards targeted management of pregnancies at risk, which is expected to drive the Prenatal Genetic Testing Market in the future. As technology evolves, discussions about expanding Non-Invasive Prenatal Testing (NIPT) beyond chromosomal abnormalities are expected to intensify. Therefore, the involvement of private clinics and biomedical professionals is crucial for facilitating access, particularly in underpenetrated regions. Validation studies serve as a central strategy to attract customers. While establishing clear guidelines and services to address potential medical and ethical issues is imperative for the responsible future use of NIPT, leveraging complementary informatics technologies to enhance data analysis and reporting capabilities will be vital for expediting new product development. Additionally, expanding the core intellectual property portfolio and refining sample preparation technology are essential aspects of staying at the forefront of NIPT advancements. Prenatal Genetic Testing Market Challenge: Legal and Regulatory Frameworks Prenatal genetic testing is subject to many legal and regulatory frameworks across the world. Harmonizing these regulations to ensure ethical standards, patient privacy, and consistent practices poses a challenge for the Global Prenatal Genetic Testing Market. For example - Centers for Medicare and Medicaid Services (CMS) enforces regulations to govern the analytical validity of clinical genetic tests, while federal oversight of the clinical validity of most genetic tests is currently absent. Recognizing this gap, the FDA has put forth new policies aimed at strengthening the regulation of analytical validity and broadening oversight to encompass the clinical validity of genetic tests. CMS oversees clinical laboratories, including those engaged in clinical genetic testing, through the Clinical Laboratory Improvement Amendments (CLIA) program. Enacted in 1988, CLIA mandates a certification process that laboratories must undergo to lawfully perform clinical testing. The primary goal of CLIA is to assess and ensure the quality of clinical testing, encompassing the validation of procedures and the qualifications of the technicians administering the tests. Additionally, the program includes proficiency testing for certain types of tests.Prenatal Genetic Testing Market Segment Analysis
Based on Tests: The market is segmented into Diagnostic Tests (sub-segments: Amniocentesis, Chorion villus biopsy, Ultrasonography and Maternal serum markers) and Screening Tests (sub-segments: Carrier Screening, Sequential Screening and Maternal Serum Quad Screening). The Diagnostic Tests segment is expected to grow at a high rate during the forecast period and among which the Non-invasive prenatal testing (NIPT) held the largest share. This is attributed to NIPT's non-invasive nature, lower risk, and wider range of conditions that is contributing to its dominant share.The Screening Tests segment held the largest Prenatal Genetic Testing Market share in 2023 among which, the Carrier Screening segment held the largest share. It is attributed to its ability to identify potential genetic diseases carriers before conception or early in pregnancy, promoting informed reproductive choices. This majorly contributes to its market lead.
Prenatal Genetic Testing Market Regional Insights
North American Prenatal Genetic Testing Market dominated the global market with the largest share in 2023. This is attributed to the high research and development in the healthcare sector. The increase in incidence of all hypertensive disorders of pregnancy is the driving factor for global prenatal genetic testing in North America. Prenatal genetic screenings are generally done in the countries of North America for the patients that would be benefited from the genetic counselling. Doctors and clinicians recommend the prenatal genetic testing as a precaution to avoid unnecessary health risks to both mother and fetus. Asia Pacific Prenatal Genetic Testing Market is expected to grow at a high rate during the forecast period. This is attributed to the increasing disposable income, rising awareness of genetic disorders, and expanding healthcare facilities. Several countries in the region have initiated government-supported programs to promote prenatal care and genetic screening. These initiatives aim to improve awareness, accessibility, and affordability of prenatal genetic testing services. In the region, China is the largest market for Prenatal Genetic Testing. The country is experiencing a growth in prenatal genetic testing, which is driven by a growing middle class, advanced healthcare infrastructure and rising awareness.Prenatal Genetic Testing Market Scope: Inquire before buying
Global Prenatal Genetic Testing Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 12.13 Bn. Forecast Period 2024 to 2030 CAGR: 5.6% Market Size in 2030: US $ 17.76 Bn. Segments Covered: By Tests Diagnostic Tests Amniocentesis Chorion villus biopsy Ultrasonography Maternal serum markers Screening Tests Carrier Screening Sequential Screening Maternal Serum Quad Screening By End Users Hospitals Specialty clinics Diagnostic centers Global Prenatal Genetic Testing Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Prenatal Genetic Testing Key Players
North America: 1. Bio-Rad Laboratories Inc. [Headquarters: Hercules, California, USA] 2. Agilent Technologies Inc. [Headquarters: Santa Clara, California, USA] 3. Illumina Inc. [Headquarters: San Diego, California, USA] 4. Natera Inc. [Headquarters: San Carlos, California, USA] 5. Myriad Genetics Inc. [Headquarters: Salt Lake City, Utah, USA] 6. PreventionGenetics [Headquarters: Marshfield, Wisconsin, USA] 7. Abbott Laboratories [Headquarters: Abbott Park, Illinois, USA] 8. Thermo Fisher Scientific [Headquarters: Waltham, Massachusetts, USA] 9. QIAGEN [Headquarters: Germantown, Maryland, USA] Europe: 1. Roche Holding AG [Headquarters: Basel, Switzerland] 2. Eurofins Scientific [Headquarters: Luxembourg] 3. Premaitha Health plc [Headquarters: Manchester, United Kingdom] Asia Pacific: 1. Strand Life Sciences [Headquarters: Bangalore, India]Frequently Asked Questions:
1. Which region held the largest Prenatal Genetic Testing Market share in 2023? Ans: North America region held the largest market share in 2023. 2. What is the expected growth rate of Global Prenatal Genetic Testing Market during the forecast period? Ans: The Global market is expected to grow at a CAGR of 5.60% during forecasting period. 3. What is scope of the Global Prenatal Genetic Testing market report? Ans: Global Prenatal Genetic Testing Market report helps with the PESTLE, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Prenatal Genetic Testing Industry? Ans: The key players in the Global Prenatal Genetic Testing Industry are – Bio-Rad Laboratories Inc., Agilent Technologies Inc., Illumina Inc., Natera Inc., Myriad Genetics Inc., PreventionGenetics, Abbott laboratories, Thermo fisher Scientific, Qaigen, Strand life sciences, Roche Holding AG, Eurofins scientific, and Premaitha Health plc. 5. What is the forecast period of the Prenatal Genetic Testing market research? Ans: The Global Prenatal Genetic Testing Market research is from 2024 to 2030.
1. Prenatal Genetic Testing Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Prenatal Genetic Testing Market: Dynamics 2.1. Prenatal Genetic Testing Market Trends by Region 2.1.1. North America Prenatal Genetic Testing Market Trends 2.1.2. Europe Prenatal Genetic Testing Market Trends 2.1.3. Asia Pacific Prenatal Genetic Testing Market Trends 2.1.4. Middle East and Africa Prenatal Genetic Testing Market Trends 2.1.5. South America Prenatal Genetic Testing Market Trends 2.2. Prenatal Genetic Testing Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Prenatal Genetic Testing Market Drivers 2.2.1.2. North America Prenatal Genetic Testing Market Restraints 2.2.1.3. North America Prenatal Genetic Testing Market Opportunities 2.2.1.4. North America Prenatal Genetic Testing Market Challenges 2.2.2. Europe 2.2.2.1. Europe Prenatal Genetic Testing Market Drivers 2.2.2.2. Europe Prenatal Genetic Testing Market Restraints 2.2.2.3. Europe Prenatal Genetic Testing Market Opportunities 2.2.2.4. Europe Prenatal Genetic Testing Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Prenatal Genetic Testing Market Drivers 2.2.3.2. Asia Pacific Prenatal Genetic Testing Market Restraints 2.2.3.3. Asia Pacific Prenatal Genetic Testing Market Opportunities 2.2.3.4. Asia Pacific Prenatal Genetic Testing Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Prenatal Genetic Testing Market Drivers 2.2.4.2. Middle East and Africa Prenatal Genetic Testing Market Restraints 2.2.4.3. Middle East and Africa Prenatal Genetic Testing Market Opportunities 2.2.4.4. Middle East and Africa Prenatal Genetic Testing Market Challenges 2.2.5. South America 2.2.5.1. South America Prenatal Genetic Testing Market Drivers 2.2.5.2. South America Prenatal Genetic Testing Market Restraints 2.2.5.3. South America Prenatal Genetic Testing Market Opportunities 2.2.5.4. South America Prenatal Genetic Testing Market Challenges 2.3. PORTER’s Five Types Analysis 2.4. PESTLE Analysis 2.5. Value Chain Analysis 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For the Prenatal Genetic Testing Industry 2.8. The Global Pandemic Impact on the Prenatal Genetic Testing Market 3. Prenatal Genetic Testing Market: Global Market Size and Forecast (by Value) (2023-2030) 3.1. Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 3.1.1. Diagnostic Tests 3.1.1.1. Non-invasive prenatal testing (NIPT) 3.1.1.2. Amniocentesis 3.1.1.3. Chorion villus biopsy 3.1.1.4. Ultrasonography 3.1.1.5. Maternal serum markers 3.1.2. Screening Tests 3.1.2.1. Carrier Screening 3.1.2.2. Sequential Screening 3.1.2.3. Maternal Serum Quad Screening 3.2. Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 3.2.1. Hospitals 3.2.2. Specialty clinics 3.2.3. Diagnostic centers 3.3. Prenatal Genetic Testing Market Size and Forecast, by Region (2023-2030) 3.3.1. North America 3.3.2. Europe 3.3.3. Asia Pacific 3.3.4. Middle East and Africa 3.3.5. South America 4. North America Prenatal Genetic Testing Market Size and Forecast (by Value) (2023-2030) 4.1. North America Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 4.1.1. Diagnostic Tests 4.1.1.1. Non-invasive prenatal testing (NIPT) 4.1.1.2. Amniocentesis 4.1.1.3. Chorion villus biopsy 4.1.1.4. Ultrasonography 4.1.1.5. Maternal serum markers 4.1.2. Screening Tests 4.1.2.1. Carrier Screening 4.1.2.2. Sequential Screening 4.1.2.3. Maternal Serum Quad Screening 4.2. North America Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 4.2.1. Hospitals 4.2.2. Specialty clinics 4.2.3. Diagnostic centers 4.3. North America Prenatal Genetic Testing Market Size and Forecast, by Country (2023-2030) 4.3.1. United States 4.3.1.1. United States Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 4.3.1.1.1. Diagnostic Tests 4.3.1.1.1.1. Non-invasive prenatal testing (NIPT) 4.3.1.1.1.2. Amniocentesis 4.3.1.1.1.3. Chorion villus biopsy 4.3.1.1.1.4. Ultrasonography 4.3.1.1.1.5. Maternal serum markers 4.3.1.1.2. Screening Tests 4.3.1.1.2.1. Carrier Screening 4.3.1.1.2.2. Sequential Screening 4.3.1.1.2.3. Maternal Serum Quad Screening 4.3.1.2. United States Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 4.3.1.2.1. Hospitals 4.3.1.2.2. Specialty clinics 4.3.1.2.3. Diagnostic centers 4.3.2. Canada 4.3.2.1. Canada Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 4.3.2.1.1. Diagnostic Tests 4.3.2.1.1.1. Non-invasive prenatal testing (NIPT) 4.3.2.1.1.2. Amniocentesis 4.3.2.1.1.3. Chorion villus biopsy 4.3.2.1.1.4. Ultrasonography 4.3.2.1.1.5. Maternal serum markers 4.3.2.1.2. Screening Tests 4.3.2.1.2.1. Carrier Screening 4.3.2.1.2.2. Sequential Screening 4.3.2.1.2.3. Maternal Serum Quad Screening 4.3.2.2. Canada Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 4.3.2.2.1. Hospitals 4.3.2.2.2. Specialty clinics 4.3.2.2.3. Diagnostic centers 4.3.2.3. Mexico 4.3.2.4. Mexico Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 4.3.2.4.1. Diagnostic Tests 4.3.2.4.1.1. Non-invasive prenatal testing (NIPT) 4.3.2.4.1.2. Amniocentesis 4.3.2.4.1.3. Chorion villus biopsy 4.3.2.4.1.4. Ultrasonography 4.3.2.4.1.5. Maternal serum markers 4.3.2.4.2. Screening Tests 4.3.2.4.2.1. Carrier Screening 4.3.2.4.2.2. Sequential Screening 4.3.2.4.2.3. Maternal Serum Quad Screening 4.3.2.5. Mexico Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 4.3.2.5.1. Hospitals 4.3.2.5.2. Specialty clinics 4.3.2.5.3. Diagnostic centers 5. Europe Prenatal Genetic Testing Market Size and Forecast by Segmentation (by Value) (2023-2030) 5.1. Europe Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 5.2. Europe Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 5.3. Europe Prenatal Genetic Testing Market Size and Forecast, by Country (2023-2030) 5.3.1. United Kingdom 5.3.1.1. United Kingdom Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 5.3.1.2. United Kingdom Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 5.3.2. France 5.3.2.1. France Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 5.3.2.2. France Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 5.3.3. Germany 5.3.3.1. Germany Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 5.3.3.2. Germany Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 5.3.4. Italy 5.3.4.1. Italy Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 5.3.4.2. Italy Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 5.3.5. Spain 5.3.5.1. Spain Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 5.3.5.2. Spain Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 5.3.6. Sweden 5.3.6.1. Sweden Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 5.3.6.2. Sweden Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 5.3.7. Austria 5.3.7.1. Austria Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 5.3.7.2. Austria Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 5.3.8. Rest of Europe 5.3.8.1. Rest of Europe Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 5.3.8.2. Rest of Europe Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 6. Asia Pacific Prenatal Genetic Testing Market Size and Forecast by Segmentation (by Value) (2023-2030) 6.1. Asia Pacific Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 6.2. Asia Pacific Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 6.3. Asia Pacific Prenatal Genetic Testing Market Size and Forecast, by Country (2023-2030) 6.3.1. China 6.3.1.1. China Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 6.3.1.2. China Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 6.3.2. S Korea 6.3.2.1. S Korea Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 6.3.2.2. S Korea Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 6.3.3. Japan 6.3.3.1. Japan Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 6.3.3.2. Japan Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 6.3.4. India 6.3.4.1. India Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 6.3.4.2. India Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 6.3.5. Australia 6.3.5.1. Australia Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 6.3.5.2. Australia Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 6.3.6. Indonesia 6.3.6.1. Indonesia Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 6.3.6.2. Indonesia Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 6.3.7. Malaysia 6.3.7.1. Malaysia Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 6.3.7.2. Malaysia Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 6.3.8. Vietnam 6.3.8.1. Vietnam Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 6.3.8.2. Vietnam Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 6.3.9. Taiwan 6.3.9.1. Taiwan Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 6.3.9.2. Taiwan Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 6.3.10. Rest of Asia Pacific 6.3.10.1. Rest of Asia Pacific Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 6.3.10.2. Rest of Asia Pacific Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 7. Middle East and Africa Prenatal Genetic Testing Market Size and Forecast (by Value) (2023-2030) 7.1. Middle East and Africa Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 7.2. Middle East and Africa Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 7.3. Middle East and Africa Prenatal Genetic Testing Market Size and Forecast, by Country (2023-2030) 7.3.1. South Africa 7.3.1.1. South Africa Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 7.3.1.2. South Africa Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 7.3.2. GCC 7.3.2.1. GCC Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 7.3.2.2. GCC Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 7.3.3. Nigeria 7.3.3.1. Nigeria Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 7.3.3.2. Nigeria Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 7.3.4. Rest of ME&A 7.3.4.1. Rest of ME&A Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 7.3.4.2. Rest of ME&A Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 8. South America Prenatal Genetic Testing Market Size and Forecast (by Value) (2023-2030) 8.1. South America Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 8.2. South America Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 8.3. South America Prenatal Genetic Testing Market Size and Forecast, by Country (2023-2030) 8.3.1. Brazil 8.3.1.1. Brazil Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 8.3.1.2. Brazil Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 8.3.2. Argentina 8.3.2.1. Argentina Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 8.3.2.2. Argentina Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 8.3.3. Rest Of South America 8.3.3.1. Rest Of South America Prenatal Genetic Testing Market Size and Forecast, by Test (2023-2030) 8.3.3.2. Rest Of South America Prenatal Genetic Testing Market Size and Forecast, by End user (2023-2030) 9. Global Prenatal Genetic Testing Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Product Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Prenatal Genetic Testing Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Bio-Rad Laboratories Inc. 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Details on Partnership 10.1.7. Recent Developments 10.2. Agilent Technologies Inc. 10.3. Illumina Inc. 10.4. Natera Inc. 10.5. Myriad Genetics Inc. 10.6. PreventionGenetics 10.7. Abbott laboratories 10.8. Thermo fisher Scientific 10.9. Qaigen 10.10. Strand life sciences 10.11. Roche Holding AG 10.12. Eurofins scientific 10.13. Premaitha Health plc 11. Key Findings 12. Industry Recommendations 13. Prenatal Genetic Testing Market: Research Methodology 14. Terms and Glossary